Effect of gamma-aminobutyric acid on brain serotonin and catecholamines.
D006916:5-Hydroxytryptophan / Q000378:metabolism; D000085:Acetates / Q000494:pharmacology; D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002262:Carboxy-Lyases / Q000378:metabolism; D002498:Centrifugation; D004296:Dopa Decarboxylase / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D005470:Fluorometry; D006321:Heart / Q000187:drug effects; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008636:Mesencephalon / Q000201:enzymology; D008995:Monoamine Oxidase / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D013057:Spectrum Analysis; D013154:Spleen / Q000187:drug effects / Q000378:metabolism
D000085:Acetates; D000613:Aminobutyrates; D012701:Serotonin; D012110:Reserpine; D006916:5-Hydroxytryptophan; D007490:Iproniazid; D008995:Monoamine Oxidase; D002262:Carboxy-Lyases; D004296:Dopa Decarboxylase; D004298:Dopamine; D009638:Norepinephrine